{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5915,"total_is_capped":false,"direct_labels_cover":18,"predictions_cover":5915,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"cb00e213aa97","filters":{"topic":"Atrial Fibrillation Management and Outcomes"}},"results":[{"id":"W2136489990","doi":"10.1056/nejmoa0905561","title":"Dabigatran versus Warfarin in Patients with Atrial Fibrillation","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11200,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Cilag; Eisai; Sanofi; GlaxoSmithKline; Servier; Daiichi-Sankyo; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dabigatran; Medicine; Warfarin; Atrial fibrillation; Stroke (engine); Confidence interval; Anesthesia; Internal medicine; Relative risk; Direct thrombin inhibitor","retraction":null,"screen_n_in":null,"score":{"opus":0.03909239909545998,"gpt":0.3114854478571458,"spread":0.2723930487616859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000406176,0.0001144307,0.0004136514,0.0002758136,0.00002185274,0.000006459161,0.00004957843,0.00004644628,0.0001155827],"category_scores_gemma":[0.0003246567,0.00006791245,0.00008257417,0.0002505242,0.00002708628,0.0001324275,0.000005168095,0.0001606887,0.000002799363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005742611,"about_ca_system_score_gemma":0.00007172948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001892919,"about_ca_topic_score_gemma":0.00001238797,"domain_scores_codex":[0.9987161,0.00003939835,0.0004816206,0.00009152922,0.0005353089,0.0001360166],"domain_scores_gemma":[0.9992231,0.0001362857,0.0002563275,0.0001012545,0.0001234912,0.0001595178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02246091,0.000005441779,0.6982275,0.000009435101,0.00007671521,0.00004545093,0.0002921404,0.0005006067,0.00006798955,0.0001706039,0.0006498809,0.2774934],"study_design_scores_gemma":[0.1869045,0.005611389,0.7828957,0.0001827683,0.0002221833,0.00001983305,0.00003382509,0.00003445873,0.00001872501,0.0001773425,0.02382976,0.00006948915],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816736,0.0002850093,0.0001640314,0.01549166,0.0007012004,0.0002144572,3.134715e-7,0.0000108794,0.001458842],"genre_scores_gemma":[0.9890037,0.00007854548,0.0005506675,0.0001313872,0.01000651,1.00988e-8,0.00001241784,0.000007600531,0.0002091795],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2774239,"threshold_uncertainty_score":0.2769389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162508946","doi":"10.1056/nejmoa1107039","title":"Apixaban versus Warfarin in Patients with Atrial Fibrillation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":8914,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Apixaban; Atrial fibrillation; Warfarin; Cardiology; Medicine; Internal medicine; Rivaroxaban","retraction":null,"screen_n_in":null,"score":{"opus":0.07181510108788432,"gpt":0.3023844160813428,"spread":0.2305693149934585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004285421,0.0001109739,0.0003868481,0.0002947134,0.00001951429,0.00000365226,0.0000525059,0.00004576597,0.0003860609],"category_scores_gemma":[0.0003355849,0.00006538998,0.00007665267,0.0002166127,0.00003930254,0.0001315463,0.00001262448,0.0001459106,0.000005760553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004990207,"about_ca_system_score_gemma":0.00006898251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008226634,"about_ca_topic_score_gemma":0.00002931254,"domain_scores_codex":[0.9988063,0.00004291721,0.0004698199,0.00008960909,0.0004599509,0.000131389],"domain_scores_gemma":[0.9991833,0.0001214312,0.0002961642,0.0001055749,0.0001387403,0.0001548109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02185752,0.000004536325,0.9004599,0.00001202083,0.0001109944,0.00003294211,0.0007262875,0.00003994523,0.000008740779,0.0001459611,0.0004182226,0.07618293],"study_design_scores_gemma":[0.1612622,0.003833588,0.8165382,0.0001526457,0.0002470757,0.00001463321,0.00007086552,0.00001817049,0.00001581914,0.0001212206,0.0176579,0.00006761297],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930273,0.000210587,0.0002018575,0.001924865,0.001025851,0.0002156339,3.420569e-7,0.00001022844,0.003383298],"genre_scores_gemma":[0.9915971,0.00006082128,0.0009334282,0.0000504759,0.007045691,2.497373e-8,0.000008468045,0.00001187467,0.0002921009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1394047,"threshold_uncertainty_score":0.4227096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096246254","doi":"10.1056/nejmoa1310907","title":"Edoxaban versus Warfarin in Patients with Atrial Fibrillation","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":5126,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Women's College Hospital","funders":"Biosense Webster; St. Jude Medical; Eisai; Janssen Scientific Affairs; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Medicines Company; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AtriCure; Janssen Pharmaceuticals; Gilead Sciences; Pfizer","keywords":"Edoxaban; Atrial fibrillation; Warfarin; Medicine; Cardiology; Internal medicine; Rivaroxaban","retraction":null,"screen_n_in":null,"score":{"opus":0.03519064614790252,"gpt":0.2958072714181509,"spread":0.2606166252702484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003240272,0.0001135855,0.0003975578,0.0002817217,0.00002119011,0.000009709448,0.00004977711,0.00004594282,0.0005783947],"category_scores_gemma":[0.0004111359,0.00006537051,0.00007425181,0.0002224075,0.00003579024,0.0001952998,0.00001293929,0.0001525874,0.00001679041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005941783,"about_ca_system_score_gemma":0.00006776894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001354502,"about_ca_topic_score_gemma":0.00002096774,"domain_scores_codex":[0.9987217,0.00004266078,0.0004848849,0.00008916115,0.0005200977,0.0001415029],"domain_scores_gemma":[0.999045,0.0001992238,0.0002822867,0.0001039049,0.0001976335,0.0001719909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00602422,0.000003142185,0.8619295,0.00001255632,0.0000929129,0.000010954,0.0002101851,0.000208074,0.00002382613,0.00006418322,0.002054903,0.1293655],"study_design_scores_gemma":[0.1568531,0.002759254,0.8111871,0.0001555294,0.0001630269,0.0000109177,0.00006093747,0.00006353568,0.000007437962,0.0001149917,0.02855637,0.00006778954],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868096,0.0002066967,0.0001276699,0.01021301,0.0009334245,0.0003343546,2.371416e-7,0.000009488722,0.001365582],"genre_scores_gemma":[0.9884205,0.00005701157,0.0005744184,0.00008043657,0.01032641,5.956111e-8,0.00001159374,0.00001185657,0.0005177056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1508289,"threshold_uncertainty_score":0.6333017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152623033","doi":"10.1016/s0140-6736(13)62343-0","title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","year":2013,"lang":"en","type":"review","venue":"The Lancet","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4971,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Stroke (engine); Internal medicine; Myocardial infarction; Randomized controlled trial; Relative risk; TIMI; Meta-analysis; Hazard ratio; Cardiology; Percutaneous coronary intervention; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.3597200135240151,"gpt":0.4455340600310687,"spread":0.0858140465070536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512448,0.000266067,0.01191716,0.0002184675,0.00002619085,0.00001111802,0.0001967675,0.00009737738,0.0001410786],"category_scores_gemma":[0.0004927586,0.00009468534,0.001486459,0.0009766864,0.0001124831,0.00003553726,0.00007538412,0.0001229504,8.125803e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001604504,"about_ca_system_score_gemma":0.0001076196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001295392,"about_ca_topic_score_gemma":0.00003378507,"domain_scores_codex":[0.9966962,0.0008357282,0.001621375,0.0002025376,0.0005068909,0.0001372697],"domain_scores_gemma":[0.995111,0.001677235,0.002405588,0.0006722934,0.00009862048,0.00003523719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.04205285,0.00003087228,0.5356822,0.005193376,0.3050276,3.716671e-7,0.000482802,0.001650283,4.976186e-7,0.0001690516,0.0005000643,0.10921],"study_design_scores_gemma":[0.06295287,0.0003096093,0.1616361,0.001142824,0.7233342,4.06379e-7,0.00001881442,0.00009062675,0.000003247887,0.000008530316,0.05031266,0.0001901569],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03805745,0.950838,0.00007312266,0.0005712506,0.00009681179,0.01001475,0.0001472715,0.00001390617,0.0001873875],"genre_scores_gemma":[0.1582891,0.83724,0.001548855,0.00003736369,0.001362163,0.000009723491,0.0004905119,0.0000798609,0.0009423767],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4183066,"threshold_uncertainty_score":0.8146335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2612100421","doi":"10.1016/j.hrthm.2017.05.012","title":"2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","year":2017,"lang":"en","type":"article","venue":"Heart Rhythm","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2727,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Southlake Regional Health Center; University of Toronto; McGill University; Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Arthritis Foundation; American Heart Association","keywords":"Medicine; Atrial fibrillation; Catheter ablation; Cardiology; Statement (logic); Ablation; Internal medicine; Catheter; Surgery; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.09346990444594809,"gpt":0.3831533721038061,"spread":0.289683467657858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003729298,0.0001493123,0.0003635681,0.00007905078,0.000238807,0.00005615771,0.00003052545,0.00009284294,0.0002608246],"category_scores_gemma":[0.0001546215,0.0001250923,0.0001776154,0.00003368502,0.0001065782,0.000110286,0.00004681179,0.00006786683,0.0000694027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004419847,"about_ca_system_score_gemma":0.0000318225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000113383,"about_ca_topic_score_gemma":0.000008507879,"domain_scores_codex":[0.9987563,0.00005871432,0.0004086038,0.0002586512,0.0003312179,0.0001865327],"domain_scores_gemma":[0.9989635,0.0001676091,0.0002289599,0.0004514545,0.00008699553,0.0001014167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01453576,0.0000857033,0.7466093,0.0006619911,0.001056513,0.0004689001,0.0036686,0.001575323,0.002571963,0.007229489,0.04960119,0.1719353],"study_design_scores_gemma":[0.007327061,0.0007864511,0.3147584,0.0001756308,0.000122515,0.0002765604,0.00007642175,0.003789183,0.001126784,0.0001495321,0.6711083,0.0003031376],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875972,0.0003985469,0.00002004773,0.008154674,0.0004255447,0.0006093455,0.000009236289,0.00003926635,0.002746083],"genre_scores_gemma":[0.9932713,0.0003594009,0.0006082545,0.00007765755,0.001835199,0.000001075479,0.00002752135,0.00001688969,0.003802689],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6215071,"threshold_uncertainty_score":0.5101115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118092611","doi":"10.1056/nejmoa0906598","title":"Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2571,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Dabigatran; Warfarin; Interquartile range; Hazard ratio; Direct thrombin inhibitor; Confidence interval; Anesthesia; Randomized controlled trial; Adverse effect; Internal medicine; Surgery; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.08174283182105804,"gpt":0.3693478255089999,"spread":0.2876049936879418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175675,0.0001101514,0.0006085163,0.0001750769,0.00002190683,0.00000382969,0.00009280051,0.00003858389,0.00007806077],"category_scores_gemma":[0.00006618139,0.00005281138,0.0001189303,0.0002005792,0.0000445639,0.00004975972,0.000002716316,0.000108932,0.000001725138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004634002,"about_ca_system_score_gemma":0.0000610244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005285801,"about_ca_topic_score_gemma":0.00001328106,"domain_scores_codex":[0.9988752,0.00005675777,0.0004757042,0.00006848644,0.0003980198,0.0001258585],"domain_scores_gemma":[0.9992851,0.0001967719,0.0002247095,0.0001489061,0.0000554324,0.00008908098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01003204,0.0003266647,0.0215385,0.00002943378,0.0009615429,0.001152104,0.0183868,0.00008494709,0.007024544,0.001988423,0.00329931,0.9351757],"study_design_scores_gemma":[0.2230545,0.04139045,0.5691508,0.0003021599,0.002927569,0.0006815,0.001102502,0.00003903868,0.001054948,0.001989766,0.1581671,0.000139694],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9490453,0.001506156,0.00006338272,0.04504076,0.0006685011,0.0002239425,7.342596e-7,0.000005808676,0.003445392],"genre_scores_gemma":[0.9922168,0.002341,0.000224844,0.000318353,0.004669194,1.102801e-7,0.000004784261,0.000005206787,0.000219767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.935036,"threshold_uncertainty_score":0.2153586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149388786","doi":"10.1056/nejmoa1007432","title":"Apixaban in Patients with Atrial Fibrillation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2420,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Population Health Research Institute","funders":"Bayer Vital; St. Jude Medical; Cilag; Astellas Pharma; Sanofi; Hamilton Health Sciences; GlaxoSmithKline; Institut de Cardiologie de Montréal; Servier; McMaster University; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Atrial fibrillation; Apixaban; Cardiology; Internal medicine; Medicine; Warfarin; Rivaroxaban","retraction":null,"screen_n_in":null,"score":{"opus":0.04872069212477084,"gpt":0.2871827491352683,"spread":0.2384620570104975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004291849,0.0000958887,0.0003644977,0.00029123,0.00001611935,0.000003015869,0.00004381959,0.00003816029,0.0004030622],"category_scores_gemma":[0.0002490977,0.00005436856,0.00006922596,0.0002021493,0.0000349817,0.0001227755,0.000009069439,0.0001232853,0.000004683588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003399222,"about_ca_system_score_gemma":0.00005952591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004868689,"about_ca_topic_score_gemma":0.00001368563,"domain_scores_codex":[0.9989061,0.00003965462,0.0004516925,0.00007600794,0.0004137989,0.0001127342],"domain_scores_gemma":[0.9992693,0.00007481297,0.0002856761,0.00009087093,0.000137539,0.0001417685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005477452,0.00000355767,0.9319786,0.0000114955,0.00006844667,0.00002913897,0.0007118342,0.00002439408,0.00001079432,0.0001260848,0.0004890088,0.06106913],"study_design_scores_gemma":[0.0868482,0.002382411,0.8917957,0.0001891328,0.0001821941,0.00002763643,0.00005216051,0.00001331842,0.0000153903,0.0002430025,0.0181938,0.00005704736],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936014,0.0002287929,0.000315241,0.002292724,0.0005031352,0.0002057679,2.824825e-7,0.000008594975,0.002843993],"genre_scores_gemma":[0.9912968,0.00005349556,0.001009177,0.00009073452,0.007171373,1.742895e-8,0.000006258773,0.00001034435,0.0003618107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08137075,"threshold_uncertainty_score":0.4413248,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2749380187","doi":"10.1056/nejmoa1709118","title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2412,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Daiichi Sankyo Europe; LEO Pharma; Servier; Novo Nordisk; Astellas Pharma; Fresenius Medical Care North America; Eisai; Belvoir Media Group; Ironwood Pharmaceuticals, Incorporated; Agence Nationale de la Recherche; Regado Biosciences; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Massachusetts Medical Society; Regeneron Pharmaceuticals; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; University College London; Bayer HealthCare; Sanofi; GlaxoSmithKline; Amgen; Pfizer; U.S. Department of Veterans Affairs","keywords":"Rivaroxaban; Aspirin; Medicine; Disease; Internal medicine; Cardiology; Intensive care medicine; Atrial fibrillation; Warfarin","retraction":null,"screen_n_in":null,"score":{"opus":0.08434367790045115,"gpt":0.3424579357591593,"spread":0.2581142578587081,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001026834,0.000136343,0.0007041511,0.0002009144,0.00008147448,0.00002479125,0.000150899,0.00003063096,0.0002100221],"category_scores_gemma":[0.0008341857,0.00006865084,0.0001248493,0.00008805734,0.00009722987,0.0002068952,0.00002995256,0.0001988747,0.000004199842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004167061,"about_ca_system_score_gemma":0.0002077104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002884507,"about_ca_topic_score_gemma":0.00009286188,"domain_scores_codex":[0.9985896,0.00004817956,0.0003889767,0.0001268531,0.0006725526,0.0001738589],"domain_scores_gemma":[0.998637,0.00006643681,0.0003073538,0.000461742,0.0001513894,0.0003760805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006193842,0.00001062321,0.9203302,0.00007823541,0.0004638435,0.001502816,0.0002395919,0.0002178341,0.00005203914,0.00007284457,0.001083917,0.06975421],"study_design_scores_gemma":[0.09898558,0.001226339,0.5883725,0.00114237,0.001155586,0.0003179146,0.0001551063,0.0001617194,0.00003505017,0.0001790219,0.3081427,0.000126125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.962117,0.00222185,0.001689081,0.02851319,0.0006047413,0.0004189009,9.581447e-7,0.00001620742,0.004418033],"genre_scores_gemma":[0.9879437,0.0003843917,0.0007405774,0.0002354084,0.005949803,3.365393e-7,0.000002662423,0.00001713113,0.004726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3319577,"threshold_uncertainty_score":0.27995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1583406651","doi":"10.1056/nejmoa1408288","title":"Approaches to Catheter Ablation for Persistent Atrial Fibrillation","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2290,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Jubilee Hospital; Montreal Heart Institute; McMaster University; Southlake Regional Health Center","funders":"","keywords":"Medicine; Atrial fibrillation; Pulmonary vein; Ablation; Cardiology; Internal medicine; Catheter ablation; Ablation of atrial fibrillation; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.2843725989023729,"gpt":0.3438737696510423,"spread":0.05950117074866934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011334,0.0001003327,0.0003641719,0.0002359689,0.00002974629,0.00001022215,0.00004645302,0.00004661018,0.00003747417],"category_scores_gemma":[0.0009414793,0.00006428043,0.0002403432,0.0001372861,0.00001849995,0.00009687855,0.00001192711,0.00006677297,0.000006418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007969162,"about_ca_system_score_gemma":0.0001078544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001338253,"about_ca_topic_score_gemma":0.000003701675,"domain_scores_codex":[0.998861,0.00003797758,0.000455127,0.00009633003,0.0004294988,0.0001200671],"domain_scores_gemma":[0.9989741,0.0001339253,0.000239764,0.0000974642,0.000205734,0.0003490529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02096866,0.00001641877,0.1599091,0.0001692155,0.001118897,0.00002733619,0.01389384,0.02978739,0.0009080629,0.002423592,0.08565471,0.6851228],"study_design_scores_gemma":[0.100141,0.008456781,0.01239756,0.0002187768,0.001263077,0.0002658204,0.0009324118,0.003204877,0.0001111452,0.001421134,0.8714187,0.0001687903],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7205426,0.002520968,0.05782998,0.2096815,0.003924118,0.001631523,0.000002935881,0.00004217229,0.003824129],"genre_scores_gemma":[0.9493815,0.00002875479,0.006400476,0.000270519,0.04145369,2.274735e-7,0.00001877985,0.00001495725,0.002431103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7857639,"threshold_uncertainty_score":0.262128,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065028337","doi":"10.1056/nejmoa1313600","title":"Cryptogenic Stroke and Underlying Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Atrial fibrillation; Medicine; Stroke (engine); Internal medicine; Hazard ratio; Cardiology; Confidence interval; Clinical endpoint; Randomized controlled trial; Randomization","retraction":null,"screen_n_in":null,"score":{"opus":0.07711321169335796,"gpt":0.3452822376724284,"spread":0.2681690259790705,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009112854,0.0001008184,0.0004020727,0.0002098261,0.00004782045,0.00001158743,0.00003667147,0.00004843904,0.0002246418],"category_scores_gemma":[0.0008372488,0.00006552705,0.0001127244,0.00009965496,0.00004640586,0.00009826792,0.00001548831,0.0001279734,0.000005364736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002254933,"about_ca_system_score_gemma":0.00004610571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000156051,"about_ca_topic_score_gemma":0.000004247078,"domain_scores_codex":[0.998907,0.0000671532,0.0004475476,0.00008721482,0.0003762621,0.0001147824],"domain_scores_gemma":[0.998954,0.0003654189,0.0002844653,0.00009019052,0.00009756447,0.0002083738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001921195,0.000001207147,0.2329695,0.00005704596,0.0002559877,0.00001960809,0.0004570927,0.000236548,0.004595182,0.00215736,0.003073564,0.7542557],"study_design_scores_gemma":[0.1169899,0.003006797,0.2089655,0.0003327687,0.001037366,0.0007527055,0.0002029659,0.001250115,0.00009805556,0.003008915,0.6641965,0.0001585001],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9491391,0.002315001,0.01338605,0.02950318,0.001218542,0.0001829812,4.020783e-7,0.00002242393,0.004232306],"genre_scores_gemma":[0.9729664,0.0003638596,0.00144732,0.0002100032,0.02319282,1.505897e-8,0.000003023281,0.00001068415,0.001805828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7540972,"threshold_uncertainty_score":0.2672116,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113089341","doi":"10.1056/nejmoa0901301","title":"Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2103,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Aspirin; Atrial fibrillation; Clopidogrel; Medicine; Internal medicine; Cardiology; Stroke (engine)","retraction":null,"screen_n_in":null,"score":{"opus":0.01655465773445918,"gpt":0.310299120918681,"spread":0.2937444631842218,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008694271,0.0001203287,0.0006116065,0.0004060022,0.00001257947,0.000003281247,0.00005136364,0.00004428427,0.00006962143],"category_scores_gemma":[0.0006343611,0.00006716935,0.0000944846,0.0003463287,0.0000195099,0.00007845635,0.000007835956,0.0001165128,0.000002472462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003996147,"about_ca_system_score_gemma":0.00004682416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001589302,"about_ca_topic_score_gemma":0.000005102102,"domain_scores_codex":[0.9985658,0.00009343411,0.000578396,0.00008903351,0.0005505279,0.0001228375],"domain_scores_gemma":[0.9990042,0.0002509423,0.0003273933,0.0001069215,0.0001407449,0.0001697484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01519986,0.000003296501,0.6863642,0.00002899305,0.00004834818,0.00001298648,0.0001855166,0.0004654797,0.0001224674,0.00002785578,0.0005627795,0.2969782],"study_design_scores_gemma":[0.1206766,0.02523075,0.8400034,0.0006496112,0.0002692358,0.0000140005,0.00001058779,0.00002312092,0.0002119886,0.00005200705,0.01278863,0.00007006097],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921045,0.000180872,0.0002038067,0.006297139,0.0003209753,0.0004177465,4.813799e-7,0.00000646426,0.000468025],"genre_scores_gemma":[0.9934949,0.0000253715,0.0004229113,0.0001521961,0.005732499,2.747438e-8,0.000008860649,0.000007508475,0.0001557796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2969081,"threshold_uncertainty_score":0.2739086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2154658516","doi":"10.1056/nejmoa1105575","title":"Subclinical Atrial Fibrillation and the Risk of Stroke","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2085,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Atrial fibrillation; Medicine; Subclinical infection; Cardiology; Hazard ratio; Internal medicine; Stroke (engine); Embolism; Risk factor; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.05450986573890983,"gpt":0.348757761323524,"spread":0.2942478955846142,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003118285,0.00007951156,0.000508471,0.0001043555,0.00003421324,0.000003464578,0.00004137752,0.00004674514,0.0001270974],"category_scores_gemma":[0.002830673,0.00003629399,0.0001888923,0.00009043998,0.0001673596,0.0000912606,0.00001936931,0.0001769012,0.000001661079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009713636,"about_ca_system_score_gemma":0.00003770917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003912728,"about_ca_topic_score_gemma":0.000002528278,"domain_scores_codex":[0.9986212,0.0001824689,0.0006429384,0.00004729549,0.0003991451,0.0001069452],"domain_scores_gemma":[0.9975111,0.001501429,0.0006121812,0.0001014111,0.000104426,0.0001694459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005959123,0.000001635953,0.9015358,0.00001826636,0.0002775222,0.000002153674,0.0006726886,0.00003441218,0.00009611448,0.001243931,0.001248616,0.08890972],"study_design_scores_gemma":[0.1704236,0.001103743,0.6723132,0.0001439516,0.002410595,0.0002483827,0.0002875931,0.000217595,0.00006466162,0.0009853404,0.1517335,0.00006786591],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691116,0.007287169,0.0009100601,0.02034338,0.001160112,0.0001916391,0.000001192054,0.00000529636,0.0009895719],"genre_scores_gemma":[0.9639984,0.002789693,0.0004612772,0.00008732225,0.03208547,1.550765e-8,0.000001600756,0.000006105977,0.0005700823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2292226,"threshold_uncertainty_score":0.3388785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117677020","doi":"10.1056/nejmoa1112277","title":"Rivaroxaban in Patients with a Recent Acute Coronary Syndrome","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1887,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; Genentech; Eisai; Symetis; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Amarin Corporation; Medicure; Biogen; GlaxoSmithKline; Pfizer; IC Design Education Center; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rivaroxaban; Acute coronary syndrome; Medicine; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction; Atrial fibrillation; Warfarin","retraction":null,"screen_n_in":null,"score":{"opus":0.04840318230791097,"gpt":0.2845888985375182,"spread":0.2361857162296072,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003719422,0.0001188617,0.0004544195,0.0002729914,0.00001740115,0.000002442153,0.00007457336,0.00003796288,0.000844627],"category_scores_gemma":[0.0001277191,0.00006621238,0.00004208853,0.0002320629,0.00004795594,0.0001132418,0.00001701554,0.0001924045,0.000006916276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004914427,"about_ca_system_score_gemma":0.0000689353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002690803,"about_ca_topic_score_gemma":0.000008186786,"domain_scores_codex":[0.9988064,0.00004051195,0.00045941,0.00009144872,0.0004541517,0.0001480913],"domain_scores_gemma":[0.999175,0.00004930947,0.0002609626,0.0001212419,0.000184991,0.0002084842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004756332,0.00003077899,0.9537628,0.00001276235,0.0001985301,0.0007883592,0.0006869762,0.000001537643,0.00001468624,0.00005768433,0.00134237,0.03834718],"study_design_scores_gemma":[0.07069468,0.004390223,0.9106444,0.0002867634,0.0003147041,0.0004920178,0.00006273428,0.000002330105,0.0000107364,0.000180858,0.01285444,0.00006615424],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919659,0.0001774073,0.00013406,0.005158731,0.0004009369,0.0002218333,5.909693e-7,0.000009291351,0.001931196],"genre_scores_gemma":[0.9967422,0.0002436838,0.001159438,0.0004949637,0.0006951466,1.606854e-7,0.000008298903,0.00001345087,0.000642652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06593835,"threshold_uncertainty_score":0.9248074,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992956108","doi":"10.1007/s10840-012-9672-7","title":"2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","year":2012,"lang":"en","type":"review","venue":"Journal of Interventional Cardiac Electrophysiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1688,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Western University","funders":"","keywords":"Medicine; Atrial fibrillation; Heart Rhythm; Catheter ablation; Cardiology; Internal medicine; Randomized controlled trial; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2213930645276033,"gpt":0.4377005941171691,"spread":0.2163075295895658,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001483995,0.000334567,0.001467221,0.0007112949,0.0001999016,0.00003615153,0.00005492783,0.0002424592,0.00009357251],"category_scores_gemma":[0.0001764563,0.0002608057,0.001092121,0.0002425756,0.000136112,0.0001300357,0.00008368831,0.0003607924,0.000002131151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003397932,"about_ca_system_score_gemma":0.0001737855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005829107,"about_ca_topic_score_gemma":6.358416e-7,"domain_scores_codex":[0.9958487,0.001128092,0.001841141,0.0003524079,0.0004918434,0.0003378735],"domain_scores_gemma":[0.9965799,0.001206077,0.001219285,0.0001397274,0.000709018,0.000145956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03772466,0.0001525091,0.00003458033,0.003544675,0.003575761,0.000008734936,0.000161082,0.000009263171,0.00003057361,0.004663188,0.01343342,0.9366615],"study_design_scores_gemma":[0.009024125,0.01862963,0.00007355665,0.002557932,0.002017694,0.0002618127,0.00008043017,0.00001472411,0.00007009262,0.001374406,0.9656095,0.0002860886],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009262783,0.9818149,0.0003477789,0.001048157,0.001054658,0.006248781,0.0001207437,0.0000231163,0.00007904263],"genre_scores_gemma":[0.004571683,0.9852055,0.007183572,0.00002559281,0.002179157,0.0001087327,0.0003487103,0.00005115268,0.0003259541],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9521761,"threshold_uncertainty_score":0.9999844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131260805","doi":"10.1056/nejmoa0708789","title":"Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1579,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université de Montréal; Population Health Research Institute; London Health Sciences Centre; Libin Cardiovascular Institute of Alberta; Montreal Heart Institute","funders":"","keywords":"Atrial fibrillation; Medicine; Cardiology; Heart failure; Internal medicine; Sinus rhythm; Rhythm; Heart Rhythm; Normal Sinus Rhythm","retraction":null,"screen_n_in":null,"score":{"opus":0.0450234804415037,"gpt":0.3137842978059442,"spread":0.2687608173644406,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008523162,0.0001392365,0.0006691462,0.0001749041,0.00009361029,0.000007829904,0.00003085456,0.00006980474,0.00009071658],"category_scores_gemma":[0.001352324,0.0000914003,0.0001923922,0.00009864158,0.00008050899,0.0001213421,0.000005780624,0.0001265244,0.000002658225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003226606,"about_ca_system_score_gemma":0.0001081611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001302135,"about_ca_topic_score_gemma":0.000005962385,"domain_scores_codex":[0.9987936,0.0000799558,0.0005398652,0.000113807,0.0003083168,0.0001644819],"domain_scores_gemma":[0.9979641,0.001151593,0.0003183428,0.00009262895,0.0002315145,0.0002418459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1848327,0.00001221947,0.5126096,0.000284717,0.003128129,0.000379861,0.001702517,0.002932067,0.01137267,0.002587182,0.1626043,0.1175541],"study_design_scores_gemma":[0.3933127,0.00371669,0.05577139,0.000116956,0.0009382754,0.0009786619,0.00007440954,0.0009350933,0.00004408801,0.0002744967,0.5437264,0.0001107588],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7837872,0.00480898,0.02522566,0.1811307,0.003378386,0.001306865,0.000009264869,0.00004143669,0.0003115264],"genre_scores_gemma":[0.962134,0.0003374636,0.001067965,0.0004914932,0.03552088,1.694139e-7,0.000007369354,0.00001470926,0.0004259715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4568382,"threshold_uncertainty_score":0.3727196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998354077","doi":"10.1378/chest.11-2292","title":"Oral Anticoagulant Therapy","year":2012,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1503,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Dabigatran; Rivaroxaban; Medicine; Anticoagulant; Direct thrombin inhibitor; Antithrombotic; Intensive care medicine; Discovery and development of direct thrombin inhibitors; Pharmacodynamics; Adverse effect; Drug; Idarucizumab; Fondaparinux; Pharmacology; Pharmacokinetics; Warfarin; Thrombosis; Surgery; Thrombin; Internal medicine; Atrial fibrillation; Venous thromboembolism","retraction":null,"screen_n_in":null,"score":{"opus":0.4351752407716997,"gpt":0.4616067072587861,"spread":0.02643146648708639,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004685068,0.0002618212,0.001354963,0.0002052667,0.0000913835,0.00006870533,0.0001130852,0.000177524,0.0008947424],"category_scores_gemma":[0.00003665887,0.0001549637,0.0008337991,0.0001632197,0.00002892781,0.00008962149,0.00003251676,0.0004642197,0.0004456748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007993484,"about_ca_system_score_gemma":0.0001535314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":6.483086e-7,"about_ca_topic_score_gemma":8.631409e-8,"domain_scores_codex":[0.998741,0.00007969638,0.0005108386,0.0001195226,0.0002735312,0.0002754386],"domain_scores_gemma":[0.9991025,0.00006142523,0.0003768272,0.0001971638,0.00004689458,0.0002151967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000105271,0.000007492086,0.0010174,0.002818663,0.0003352191,0.00004591079,0.00001714779,2.212504e-8,3.496939e-7,0.00005782058,0.001354589,0.9943349],"study_design_scores_gemma":[0.0005409545,0.00004904968,0.0007574399,0.002112283,0.001475973,0.0009324499,0.000005802839,4.200449e-7,5.391281e-7,0.00001613114,0.9939479,0.0001610432],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001100231,0.9964911,0.00007846639,0.0002538083,0.001064352,0.0003606104,0.000001324827,0.00003030898,0.001709064],"genre_scores_gemma":[0.00001926162,0.9880034,0.00059813,0.00007535731,0.007504331,9.309575e-7,0.00002815541,0.00004669513,0.003723724],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9941738,"threshold_uncertainty_score":0.9796801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016875529","doi":"10.1056/nejmoa1300615","title":"Dabigatran versus Warfarin in Patients with Mechanical Heart Valves","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1496,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Dabigatran; Medicine; Warfarin; Atrial fibrillation; Mechanical heart; Direct thrombin inhibitor; Mechanical heart-valve; Cardiology; Internal medicine; Anesthesia; Heart valve","retraction":null,"screen_n_in":null,"score":{"opus":0.04261221827565233,"gpt":0.3048535687228124,"spread":0.2622413504471601,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000367365,0.0001135894,0.0004431932,0.0002033213,0.00001924543,0.000007711665,0.00006403226,0.00004439843,0.0006210504],"category_scores_gemma":[0.0002956472,0.00006236711,0.00006294194,0.0001793975,0.0000401557,0.000140943,0.00001403311,0.0002191941,0.00001510929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003846905,"about_ca_system_score_gemma":0.00006710192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001017142,"about_ca_topic_score_gemma":0.00002171658,"domain_scores_codex":[0.9987442,0.00004631007,0.0004438749,0.0000930543,0.0005161882,0.0001563498],"domain_scores_gemma":[0.9991733,0.0001807239,0.0001553072,0.0001132322,0.0001427674,0.0002346062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006195559,0.00003810572,0.9172346,0.00003367987,0.0001747203,0.00004123115,0.0003340984,0.00003281576,0.0006538549,0.0004444002,0.007315288,0.06750166],"study_design_scores_gemma":[0.140892,0.004024625,0.8305658,0.0002454405,0.0001788973,0.00002823898,0.0001088597,0.00002614373,0.00008999999,0.0003337153,0.02342588,0.00008041981],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9684761,0.0001143426,0.0001275087,0.02943686,0.0005831812,0.0002590197,1.866861e-7,0.000009761178,0.0009930282],"genre_scores_gemma":[0.9952494,0.00003171013,0.001320784,0.0003635233,0.002636373,2.676212e-7,0.000004951202,0.00001204876,0.00038097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1346965,"threshold_uncertainty_score":0.6800066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1513839038","doi":"10.1056/nejmoa1502000","title":"Idarucizumab for Dabigatran Reversal","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1454,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Idarucizumab; Medicine; Dabigatran; Hemostasis; Anesthesia; Anticoagulant; Surgery; Warfarin; Internal medicine; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.1526281816432923,"gpt":0.3796013174481788,"spread":0.2269731358048864,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001095572,0.00009673792,0.0004310357,0.0001657764,0.00002337411,0.000005913073,0.00007056709,0.00004253838,0.0001033407],"category_scores_gemma":[0.001227403,0.00005892808,0.000111962,0.0001195167,0.00004431095,0.00009148438,0.000009581218,0.0001222837,0.000005289377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004706581,"about_ca_system_score_gemma":0.0001888965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001593301,"about_ca_topic_score_gemma":0.000004226244,"domain_scores_codex":[0.9988842,0.00002977079,0.0004538331,0.00007624905,0.0004254935,0.0001304496],"domain_scores_gemma":[0.9988018,0.000171251,0.0002394827,0.0001072303,0.0002850496,0.00039524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01368696,0.00002243737,0.06291997,0.0001679979,0.0005290407,0.0003254838,0.003332414,0.0001072024,0.003781248,0.003733834,0.4846444,0.426749],"study_design_scores_gemma":[0.1261255,0.003049362,0.004814447,0.0002078133,0.0005403309,0.0007056349,0.0004542097,0.00007334575,0.0002790978,0.00310921,0.8605607,0.00008037606],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5066849,0.005834299,0.04779549,0.4060134,0.008963301,0.001324458,0.000004944639,0.0000897939,0.02328943],"genre_scores_gemma":[0.9569423,0.0001081361,0.00614302,0.0009971816,0.02991623,2.45084e-7,0.000009660028,0.00001882681,0.005864445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4502574,"threshold_uncertainty_score":0.2403017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162499932","doi":"10.1111/jth.13140","title":"Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH","year":2015,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1366,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Atrial fibrillation; Medicine; Venous thromboembolic disease; Thromboembolic disease; Cardiology; Internal medicine; Disease; Venous thromboembolism; Intensive care medicine; Thrombosis","retraction":null,"screen_n_in":null,"score":{"opus":0.1784957907970881,"gpt":0.3964059248263243,"spread":0.2179101340292362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001229108,0.00009661553,0.0007534184,0.0001406459,0.00003441961,0.000009091599,0.00009263838,0.00005862567,0.000003038183],"category_scores_gemma":[0.000968483,0.00005723766,0.0001414199,0.0002691653,0.0001717762,0.0001423951,0.0001201243,0.0001347795,1.332967e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000501436,"about_ca_system_score_gemma":0.00006302597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002624702,"about_ca_topic_score_gemma":0.00008909359,"domain_scores_codex":[0.9980348,0.0001991137,0.00123705,0.00009609348,0.0003433531,0.00008953688],"domain_scores_gemma":[0.9978228,0.0007327588,0.0009906284,0.0001768335,0.0002284021,0.00004855267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001042241,0.00005997505,0.993873,0.0000801614,0.0001528195,0.000001314368,0.002629621,0.0001072539,0.00009918788,0.00009193047,0.00003514662,0.001827375],"study_design_scores_gemma":[0.005933604,0.0003424954,0.988463,0.001138247,0.0003471394,0.000001047315,0.001563231,0.0002713365,0.00007200228,0.001792873,0.00002279533,0.00005221026],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953075,0.002026824,0.00000378451,0.002158222,0.000105495,0.0003397362,0.00001747621,0.000001076599,0.00003987469],"genre_scores_gemma":[0.990476,0.008832726,0.0005496136,0.00002630127,0.0001007233,2.764288e-7,0.000007024772,0.000006676503,6.213008e-7],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006805901,"threshold_uncertainty_score":0.2334084,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139785591","doi":"10.1056/nejmoa1207541","title":"Apixaban for Extended Treatment of Venous Thromboembolism","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1341,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"Sanofi; Bayer HealthCare; GlaxoSmithKline; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Apixaban; Venous thromboembolism; Medicine; Regimen; Intensive care medicine; Internal medicine; Atrial fibrillation; Rivaroxaban; Thrombosis; Warfarin","retraction":null,"screen_n_in":null,"score":{"opus":0.1024440574879457,"gpt":0.3778103075848138,"spread":0.2753662500968681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004481597,0.0001098102,0.0007048475,0.000167347,0.00002589552,0.000001986715,0.00004233444,0.00004073009,0.0001915125],"category_scores_gemma":[0.0002199759,0.00006245565,0.0001603343,0.00008930536,0.00004396274,0.00007832085,0.000005427836,0.00004684881,0.000002253565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000472062,"about_ca_system_score_gemma":0.00006164351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001977997,"about_ca_topic_score_gemma":0.00000163811,"domain_scores_codex":[0.9989874,0.00002724875,0.0004814072,0.00005511145,0.0002787076,0.0001700956],"domain_scores_gemma":[0.9989565,0.0002233456,0.0003463493,0.0001127287,0.000128935,0.000232165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00387107,0.0002922486,0.1025874,0.0001831473,0.001158035,0.00003258978,0.007231866,0.00001815248,0.0109541,0.003120595,0.01071019,0.8598406],"study_design_scores_gemma":[0.114216,0.01253267,0.2444074,0.0002592464,0.002088019,0.0004614886,0.0005322614,0.00002187518,0.002995356,0.001531826,0.6208311,0.0001227358],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9646738,0.009591592,0.003103244,0.0164868,0.002527572,0.000633636,0.000003241762,0.00001714211,0.002962985],"genre_scores_gemma":[0.9782556,0.0006540491,0.001761056,0.0001322044,0.0178485,4.351842e-7,0.000007351357,0.00001331846,0.001327492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8597179,"threshold_uncertainty_score":0.2546867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129906781","doi":"10.1056/nejmoa1311376","title":"Atrial Fibrillation in Patients with Cryptogenic Stroke","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1273,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Queen's University; Université Laval; University of British Columbia; University of Alberta; Thunder Bay Regional Health Sciences Centre; University of Calgary; McGill University; McMaster University; Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; Heart and Stroke Foundation; Island Health; University of Toronto; Western University","funders":"Ontario Stroke Network; University of Toronto; Canadian Stroke Network","keywords":"Medicine; Atrial fibrillation; Internal medicine; Cardiology; Stroke (engine); Asymptomatic; Ambulatory; Randomization; Randomized controlled trial; Confidence interval; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.02245783597470495,"gpt":0.2818683494322602,"spread":0.2594105134575553,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006536737,0.0001050114,0.0004258018,0.000296583,0.0000204524,0.000005958268,0.00004693392,0.00004287094,0.0001835663],"category_scores_gemma":[0.0005632877,0.0000609115,0.00009046042,0.0001753528,0.00003181683,0.0001027401,0.000009983059,0.0001393237,0.000005039803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004093634,"about_ca_system_score_gemma":0.00005514147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001787851,"about_ca_topic_score_gemma":0.00001183047,"domain_scores_codex":[0.9986987,0.00006734514,0.000484502,0.00008610629,0.0005368267,0.000126508],"domain_scores_gemma":[0.9990855,0.0002011216,0.0003101364,0.0001048114,0.0001464812,0.0001518858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004127714,0.000002331861,0.89466,0.00001329115,0.00007027108,0.000005877359,0.0001289631,0.0004579462,0.00004331699,0.0001675176,0.0005306404,0.09979212],"study_design_scores_gemma":[0.1312327,0.002705235,0.8068953,0.0001803268,0.0002204321,0.00001934597,0.00002215568,0.0001240276,0.00001360327,0.0001965185,0.05832483,0.00006553172],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905612,0.0001915168,0.00141003,0.006079002,0.0005204756,0.0001870188,4.049449e-7,0.000008573847,0.001041721],"genre_scores_gemma":[0.9861655,0.00004902141,0.0008058767,0.0001340304,0.01234232,2.35953e-8,0.000009012248,0.00001121147,0.0004830183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.127105,"threshold_uncertainty_score":0.2483899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2157822705","doi":"10.1378/chest.11-2295","title":"Evidence-Based Management of Anticoagulant Therapy","year":2012,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1260,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McMaster University","funders":"National Heart, Lung, and Blood Institute; Bayer HealthCare","keywords":"Anticoagulant therapy; Intensive care medicine; Medicine; Anticoagulant; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.5345765096883598,"gpt":0.4559405856777881,"spread":0.07863592401057173,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619562,0.0002726881,0.001391031,0.0002841927,0.00005806474,0.00003307281,0.0001741831,0.0001338462,0.0005840141],"category_scores_gemma":[0.00002322741,0.0001712639,0.0009484878,0.00026008,0.00004394704,0.0001098159,0.00004057318,0.0002868487,0.0000850771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009465252,"about_ca_system_score_gemma":0.000142826,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":6.074696e-7,"about_ca_topic_score_gemma":2.596912e-8,"domain_scores_codex":[0.9982848,0.0001003983,0.0007679321,0.0001453899,0.0004568579,0.0002446723],"domain_scores_gemma":[0.9985812,0.0001426532,0.0007366587,0.000306008,0.00007640885,0.0001571083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000038722,0.00001687474,0.001036375,0.02513891,0.0006700888,0.00005718994,0.000009554147,5.019492e-7,8.460266e-7,0.0001148383,0.0002698787,0.9726462],"study_design_scores_gemma":[0.0006369455,0.00008482335,0.001713342,0.04957694,0.003086543,0.00009331364,0.00001065804,0.00000173285,0.00000582388,0.000009687197,0.9446314,0.0001487704],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002080021,0.9971975,0.0003776284,0.0002806642,0.0005802215,0.0006710243,0.000001401143,0.00001842143,0.0008523131],"genre_scores_gemma":[0.00015028,0.9948298,0.001958168,0.00004485077,0.001782487,0.000002499575,0.00001350916,0.00003835309,0.001180016],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9724975,"threshold_uncertainty_score":0.6983941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078856783","doi":"10.1001/jama.291.14.1720","title":"A Multicenter Risk Index for Atrial Fibrillation After Cardiac Surgery","year":2004,"lang":"en","type":"article","venue":"JAMA","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1232,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institut de Cardiologie de Montréal; Karl-Franzens-Universität Graz; University of Toronto; Faculty of Medicine Siriraj Hospital, Mahidol University; University of Alberta; University of Ottawa","keywords":"Medicine; Atrial fibrillation; Internal medicine; Cardiology; Odds ratio; Cardiac surgery; Cohort study; Prospective cohort study; Confidence interval; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.03125065107475635,"gpt":0.3039370979356033,"spread":0.272686446860847,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002442776,0.0001043679,0.000284065,0.0001181674,0.00005244381,0.00003765574,0.00001977631,0.00009604079,0.00007181476],"category_scores_gemma":[0.0005428719,0.00008846903,0.0006073766,0.000111718,0.00001693091,0.0001478911,0.00002189937,0.0000560892,0.00007331644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006830323,"about_ca_system_score_gemma":0.00004091026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004581527,"about_ca_topic_score_gemma":0.000005707734,"domain_scores_codex":[0.9991885,0.00002900989,0.000252223,0.0001749652,0.0001825684,0.0001727262],"domain_scores_gemma":[0.9993064,0.0002775535,0.0001035581,0.0001644789,0.00008209203,0.00006590153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002388663,0.000001588444,0.9491272,0.00004796856,0.0001365346,0.000003205453,0.0001040048,0.0002527167,0.0000297219,0.00006448662,0.001719393,0.0461245],"study_design_scores_gemma":[0.003963768,0.00004320793,0.7888291,0.00003867548,0.0002403796,6.382667e-7,0.00002925457,0.0003398131,0.0001471021,0.0002698565,0.2059863,0.000111922],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883176,0.0003760448,0.00358556,0.004782246,0.001277616,0.001142045,0.00005186522,0.00009574357,0.000371287],"genre_scores_gemma":[0.9899186,0.00009866826,0.0009896412,0.0001790218,0.00798274,0.000004497343,0.0000817274,0.00002055492,0.0007245535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2042669,"threshold_uncertainty_score":0.3607662,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977385197","doi":"10.1016/j.jacc.2007.09.064","title":"Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation","year":2008,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1225,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Atrial fibrillation; Medicine; Fibrosis; Angiotensin II; Cardiac fibrosis; Clinical significance; Cardiology; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.07037306196505837,"gpt":0.3879653294440945,"spread":0.3175922674790361,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015185,0.0002622798,0.00485704,0.0003569929,0.00004531508,0.000003919517,0.0002170008,0.0002304687,0.000003761717],"category_scores_gemma":[0.002337422,0.0001614151,0.004072799,0.0006110066,0.0004006511,0.00005566629,0.0001544693,0.0004816983,0.00000206863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00012478,"about_ca_system_score_gemma":0.0005372147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004214908,"about_ca_topic_score_gemma":0.000001621669,"domain_scores_codex":[0.9959614,0.001114125,0.002139871,0.0002258714,0.0003667593,0.0001919846],"domain_scores_gemma":[0.9936305,0.002185531,0.003624335,0.0003269778,0.0001464122,0.00008621569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004353922,0.000003152664,0.02809369,0.001588522,0.004157715,0.0003337816,0.00001403423,0.0005196654,0.000003064444,0.0005967131,0.004437087,0.9558986],"study_design_scores_gemma":[0.002174324,0.001161091,0.004475865,0.001877832,0.00273762,0.001909837,0.00002950639,0.00001431504,2.546883e-7,0.0002003194,0.9852673,0.0001517469],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002291085,0.9935559,0.0001574835,0.0008376229,0.002115048,0.0008832364,0.00004301217,0.000006615075,0.000110004],"genre_scores_gemma":[0.001470493,0.9876171,0.001652788,0.00002407502,0.009040081,2.551918e-7,0.000003161748,0.00002808031,0.0001639694],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9808302,"threshold_uncertainty_score":0.6582316,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167423131","doi":"10.1161/circresaha.114.303211","title":"The Clinical Profile and Pathophysiology of Atrial Fibrillation","year":2014,"lang":"en","type":"review","venue":"Circulation Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1205,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiology; Internal medicine; Atrial fibrillation; Heart failure; Coronary artery disease; Population; Stroke (engine); Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.4062060062684513,"gpt":0.5620392201658536,"spread":0.1558332138974023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003984758,0.0001416913,0.001107341,0.0002383385,0.0002136078,0.00003691187,0.00009595875,0.0003277405,0.00004921759],"category_scores_gemma":[0.002540082,0.00008671873,0.0006163275,0.0004225231,0.0003220574,0.00003749796,0.0001370035,0.0003674424,0.00008476808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004136603,"about_ca_system_score_gemma":0.0002557627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007171731,"about_ca_topic_score_gemma":0.000001291777,"domain_scores_codex":[0.9966503,0.001311411,0.0009877229,0.000322802,0.0005071794,0.000220571],"domain_scores_gemma":[0.9947585,0.00401859,0.0003842399,0.0004322344,0.0003251252,0.00008123516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005360062,8.954597e-7,0.004548926,0.003554932,0.0001251454,6.315828e-7,0.000007303086,0.000005642508,5.63888e-7,0.001630423,0.0004688947,0.989603],"study_design_scores_gemma":[0.0004287491,0.0001230005,0.01001437,0.0008751126,0.0002803812,0.000002853828,0.000007223434,0.0006201311,6.344607e-8,0.0007090758,0.9868614,0.00007763946],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004490839,0.9959803,0.00004535927,0.0002788242,0.0003270109,0.002053145,0.000004729891,0.00002021391,0.0008413734],"genre_scores_gemma":[0.0009106486,0.9942161,0.00006567003,0.00000446134,0.003727327,0.000004483942,0.0001401646,0.00002454347,0.0009066267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9895254,"threshold_uncertainty_score":0.3536287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241261201","doi":"10.1093/europace/eux274","title":"2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","year":2017,"lang":"en","type":"review","venue":"EP Europace","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Southlake Regional Health Center; University of Toronto; McGill University; Université de Montréal; Montreal Heart Institute","funders":"National Center for Advancing Translational Sciences; Society of Thoracic Surgeons; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Heart Rhythm Society; American Heart Association","keywords":"Atrial fibrillation; Medicine; Catheter ablation; Cardiology; Ablation; Catheter; Statement (logic); Internal medicine; Surgery; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.263571541673923,"gpt":0.4584467567758404,"spread":0.1948752151019174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006702366,0.0004456289,0.001688025,0.0002281871,0.000158833,0.0000727724,0.0001138634,0.0002314409,0.0002226172],"category_scores_gemma":[0.0003814233,0.0003429615,0.0007145144,0.0001068728,0.0001236573,0.00007714704,0.0000974955,0.000201531,0.0001690488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001091239,"about_ca_system_score_gemma":0.0001135504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003882816,"about_ca_topic_score_gemma":0.000002687826,"domain_scores_codex":[0.9973984,0.0003337988,0.0009616921,0.000530184,0.0005122907,0.0002636271],"domain_scores_gemma":[0.9974102,0.0005562142,0.00105696,0.0007147518,0.0001150856,0.0001468292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004899296,0.000009498935,0.0004557162,0.004234848,0.0004483777,0.0001183294,0.0001776225,0.00002585324,0.000001513425,0.0001752858,0.004945723,0.9889173],"study_design_scores_gemma":[0.001700648,0.0003535948,0.0003375605,0.002703545,0.000806568,0.0000646009,0.00000970462,0.0001043432,0.000002144511,0.000006295108,0.9936209,0.0002901161],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001159149,0.9897112,0.00001504357,0.0006930035,0.0007470116,0.00185373,0.00004660281,0.00006500912,0.005709225],"genre_scores_gemma":[0.0006181957,0.9797244,0.0002003861,0.00001666345,0.002652999,0.000002111636,0.0002065556,0.00006687305,0.01651183],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9886752,"threshold_uncertainty_score":0.9999022,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2921724943","doi":"10.1056/nejmoa1817083","title":"Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1178,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta","funders":"National Institute for Health and Care Research; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Antithrombotic; Conventional PCI; Acute coronary syndrome; Percutaneous coronary intervention; Cardiology; Atrial fibrillation; Internal medicine; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.04247385189933311,"gpt":0.3281534761852061,"spread":0.285679624285873,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006278674,0.0001516744,0.0006923379,0.000361795,0.00001517704,0.000009236956,0.00006972704,0.0000752826,0.002435122],"category_scores_gemma":[0.0001355853,0.00008611459,0.0001569676,0.000286468,0.00003720523,0.0001922006,0.00001770112,0.0001937397,0.00004206142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005678458,"about_ca_system_score_gemma":0.0001360024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003392217,"about_ca_topic_score_gemma":0.00001125738,"domain_scores_codex":[0.9984642,0.00007423147,0.0006482442,0.0001303314,0.0005101716,0.0001728413],"domain_scores_gemma":[0.9990745,0.0002465689,0.0002919379,0.0001535355,0.00008481167,0.0001486923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01384796,0.000004132369,0.9444757,0.00003398146,0.0003040767,0.001103659,0.0004247404,0.0001801552,0.0006318213,0.00002831457,0.0006421229,0.03832338],"study_design_scores_gemma":[0.09202262,0.003937298,0.8733471,0.0004563074,0.0002503925,0.002946591,0.00007364459,0.0001217736,0.00001816284,0.00020984,0.02650936,0.000106933],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98685,0.001854818,0.00008003161,0.009056284,0.001488555,0.0003964214,6.102615e-7,0.00001239048,0.0002608778],"genre_scores_gemma":[0.9882657,0.002087233,0.0003627118,0.0003433407,0.005632329,9.026411e-8,0.000007283897,0.00001857562,0.003282761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07817466,"threshold_uncertainty_score":0.9984768,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038456369","doi":"10.1001/jama.2009.2029","title":"Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation","year":2010,"lang":"en","type":"article","venue":"JAMA","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1170,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Atrial fibrillation; Catheter ablation; Ablation; Adverse effect; Randomization; Catheter; Hazard ratio; Randomized controlled trial; Surgery; Internal medicine; Confidence interval; Prospective cohort study; Anesthesia; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.02641144451143121,"gpt":0.3037773705891823,"spread":0.2773659260777511,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001496733,0.00008906925,0.0002452988,0.0001272282,0.00002680524,0.00001600848,0.00002165664,0.00005467945,0.00004751277],"category_scores_gemma":[0.0000517832,0.00006633508,0.000052944,0.0001332776,0.00003865804,0.0001730687,0.000009988207,0.00009772469,0.000003035849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001190441,"about_ca_system_score_gemma":0.00001810216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006065487,"about_ca_topic_score_gemma":0.00002213187,"domain_scores_codex":[0.9992746,0.00002879753,0.0002697548,0.000136688,0.0001939056,0.00009621917],"domain_scores_gemma":[0.9995598,0.000053258,0.0001529163,0.0001321214,0.00006913747,0.00003280298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007764186,0.000006506338,0.9480655,0.00002088025,0.00002257878,4.063398e-7,0.0003622221,0.00005959832,0.0003954175,0.0001362343,0.00002794604,0.05012628],"study_design_scores_gemma":[0.006873488,0.0001972593,0.989224,0.00002044632,0.00002591765,6.414937e-7,0.00001598006,0.0009677708,0.0005015223,0.0000539506,0.002043623,0.00007542114],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982468,0.0001374793,0.00002937135,0.0006166316,0.0001647944,0.0005537029,0.000002400028,0.00001762944,0.0002311767],"genre_scores_gemma":[0.9983692,0.0000320885,0.0008066584,0.00001784576,0.0006460216,4.125675e-7,0.00004733004,0.00001056434,0.00006985127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05005085,"threshold_uncertainty_score":0.2705066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1837600385","doi":"10.1056/nejmoa1501035","title":"Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1164,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Perioperative; Bridging (networking); Warfarin; Atrial fibrillation; Anesthesia; Low molecular weight heparin; Placebo; Surgery; Randomized controlled trial; Anticoagulant; Heparin; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.04949409454674328,"gpt":0.3166180104019901,"spread":0.2671239158552469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006254468,0.00009915256,0.0003845746,0.0002819756,0.00002097314,0.00001022712,0.00003083059,0.00003447352,0.00004788384],"category_scores_gemma":[0.0005812111,0.00005912786,0.00004957232,0.0002387744,0.00003332873,0.0002159865,0.000009228792,0.0001154933,0.000002756264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008243769,"about_ca_system_score_gemma":0.0001371482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003912342,"about_ca_topic_score_gemma":0.00001148959,"domain_scores_codex":[0.998741,0.00006406483,0.0004457013,0.00008295707,0.0005611808,0.0001051475],"domain_scores_gemma":[0.9990853,0.00007622142,0.0002710619,0.00007287151,0.0003202499,0.0001742799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004028634,0.00000250099,0.9390866,0.000008472085,0.00004978086,0.0000180625,0.001064658,0.002568962,0.00002917647,0.00008358751,0.0003335912,0.05272595],"study_design_scores_gemma":[0.1215565,0.002086409,0.862474,0.0002505784,0.0001604536,0.00003454293,0.0001571926,0.0007279589,0.0000163532,0.00006673468,0.01239872,0.00007059656],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898643,0.0002470347,0.00144371,0.007102611,0.0004610699,0.0002376431,2.758303e-7,0.000008076775,0.0006352374],"genre_scores_gemma":[0.9895094,0.00002187275,0.0007568864,0.00007820444,0.009319115,2.078331e-8,0.00001478856,0.000009798375,0.0002899196],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1175279,"threshold_uncertainty_score":0.2411164,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326579808","doi":"10.1056/nejm200003303421302","title":"Amiodarone to Prevent Recurrence of Atrial Fibrillation","year":2000,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; University of Ottawa; Hamilton General Hospital; Montreal Heart Institute","funders":"","keywords":"Propafenone; Amiodarone; Medicine; Sotalol; Atrial fibrillation; Randomization; Cardioversion; Antiarrhythmic agent; Sinus rhythm; Randomized controlled trial; Clinical endpoint; Anesthesia; Cardiology; Internal medicine; Heart disease","retraction":null,"screen_n_in":null,"score":{"opus":0.04633840874022992,"gpt":0.341208154396237,"spread":0.2948697456560071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007659172,0.0001009606,0.0004925126,0.0002072359,0.00002164004,0.00000354618,0.00006758839,0.00003950105,0.001998925],"category_scores_gemma":[0.0005412213,0.00006633328,0.0001472373,0.0002672489,0.0000350137,0.00007182574,0.00001055478,0.0001056967,0.00002143814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003227694,"about_ca_system_score_gemma":0.00008871697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003064202,"about_ca_topic_score_gemma":0.000003761903,"domain_scores_codex":[0.9984944,0.00006108703,0.0007091804,0.00009023572,0.0005287929,0.0001162873],"domain_scores_gemma":[0.9990269,0.0001732537,0.0002923247,0.0001290093,0.0001482468,0.0002302431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003490821,0.000005369562,0.02798618,0.00004733874,0.0001304035,0.00002154053,0.0006598158,0.001224084,0.00117066,0.0001112422,0.00966383,0.9554887],"study_design_scores_gemma":[0.04213192,0.004290657,0.05662768,0.001018568,0.000595403,0.0002596886,0.00008263066,0.0001213106,0.0007878405,0.0007650735,0.89319,0.000129211],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9639218,0.002224544,0.0008403273,0.02845525,0.0008581182,0.0003614762,0.000001958345,0.00001220004,0.003324303],"genre_scores_gemma":[0.9717656,0.001236983,0.001828717,0.0001904394,0.02088073,4.927682e-8,0.000006637067,0.00001052766,0.004080323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9553595,"threshold_uncertainty_score":0.9989134,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2734827407","doi":"10.1056/nejmoa1707278","title":"Idarucizumab for Dabigatran Reversal — Full Cohort Analysis","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1136,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Dabigatran; Idarucizumab; Hemostasis; Anesthesia; Anticoagulant; Confidence interval; Thrombin time; Surgery; Warfarin; Partial thromboplastin time; Internal medicine; Coagulation; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.06973946782497524,"gpt":0.3745066045521178,"spread":0.3047671367271425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001303721,0.0001295732,0.0007941165,0.000330297,0.0001635595,0.00002760371,0.0001870165,0.00005779543,0.0003501567],"category_scores_gemma":[0.001366606,0.0000815903,0.0003509021,0.0001295405,0.00009658332,0.0001481028,0.0000210879,0.00015111,0.000003350447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003974967,"about_ca_system_score_gemma":0.00008879117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006431607,"about_ca_topic_score_gemma":0.000044649,"domain_scores_codex":[0.9986287,0.00002889251,0.0005744824,0.0001288043,0.0004744495,0.0001646727],"domain_scores_gemma":[0.9982209,0.0001927615,0.0006966786,0.0003569645,0.0002539022,0.0002788552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005027448,0.00001126549,0.8431528,0.00008300538,0.004158145,0.0001768662,0.0004253469,0.00006989256,0.002384751,0.0007110366,0.02433765,0.1194619],"study_design_scores_gemma":[0.08378528,0.001980731,0.6192175,0.000196898,0.01284892,0.0002694721,0.0001303562,0.0003699104,0.0002109792,0.001001671,0.2798394,0.0001489076],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7975729,0.001186562,0.03773325,0.1501087,0.002857921,0.0008284648,0.00000738176,0.00003443512,0.00967044],"genre_scores_gemma":[0.9784799,0.0002495291,0.002565445,0.0003106362,0.01429461,3.43365e-7,0.00001513428,0.00001329732,0.004071081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2555018,"threshold_uncertainty_score":0.383397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161696103","doi":"10.1056/nejmoa0803778","title":"Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1128,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Dronedarone; Atrial fibrillation; Cardiology; Internal medicine; Medicine; Amiodarone","retraction":null,"screen_n_in":null,"score":{"opus":0.02538116965813042,"gpt":0.3224809292678723,"spread":0.2970997596097419,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002159181,0.0001240011,0.0008421307,0.000383615,0.00001438201,0.000001408754,0.00005290215,0.00005940206,0.00005963519],"category_scores_gemma":[0.0008868878,0.00007637404,0.0003789243,0.0002402226,0.00002021849,0.00006685108,0.000006352439,0.0001553213,0.000003131148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005779761,"about_ca_system_score_gemma":0.00004667508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002455394,"about_ca_topic_score_gemma":0.000001407658,"domain_scores_codex":[0.9982623,0.000193281,0.0006181544,0.00009482229,0.0007114978,0.0001199798],"domain_scores_gemma":[0.999038,0.0003338779,0.0002871327,0.0001546115,0.0000683092,0.0001180351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01313463,0.000005740382,0.2034088,0.00008242696,0.0004416649,0.00009352268,0.0002752139,0.005121152,0.001143851,0.0001305404,0.0006411471,0.7755213],"study_design_scores_gemma":[0.2985043,0.03352422,0.5990436,0.001883461,0.002051658,0.0003077165,0.00004240187,0.0002748916,0.002192748,0.0008672152,0.06110726,0.0002005],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886154,0.002683191,0.0002700437,0.006548199,0.0006233293,0.0003143013,2.616451e-7,0.00000710525,0.0009381723],"genre_scores_gemma":[0.9882814,0.0004378598,0.00009091408,0.00006316844,0.01091643,2.616213e-8,0.00000448287,0.00000723206,0.000198465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7753208,"threshold_uncertainty_score":0.3114443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2174386486","doi":"10.1056/nejmoa1510991","title":"Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1042,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Rivaroxaban; Medicine; Apixaban; Placebo; Bolus (digestion); Prothrombin complex concentrate; Liter; Anesthesia; Anticoagulant; Internal medicine; Warfarin; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.1557351738650956,"gpt":0.3718487053405768,"spread":0.2161135314754812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009540767,0.00009330698,0.0004260666,0.0001044599,0.0000256151,0.000004234773,0.00007812803,0.00004353253,0.0001036149],"category_scores_gemma":[0.001320187,0.00004511023,0.0001050302,0.0001099607,0.00006582116,0.00008555235,0.00001665806,0.00013806,0.000001190358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003153541,"about_ca_system_score_gemma":0.0001451585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004436583,"about_ca_topic_score_gemma":0.00000968212,"domain_scores_codex":[0.9989572,0.00004317318,0.0003683041,0.00006450441,0.0004599172,0.0001068732],"domain_scores_gemma":[0.9984549,0.0005854013,0.000380949,0.0001231482,0.0002560439,0.0001995187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01852284,0.00004672038,0.1706926,0.0002362893,0.0009544196,0.00006029871,0.003907739,0.0001289644,0.01851972,0.0004835546,0.2577936,0.5286532],"study_design_scores_gemma":[0.1092165,0.004499113,0.06770217,0.0002953951,0.0008941705,0.0001946054,0.000664136,0.0003248549,0.003088995,0.0006085811,0.8123983,0.0001132522],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8880327,0.00226365,0.01090072,0.09371863,0.003101683,0.000677928,0.000007815946,0.00001524359,0.001281647],"genre_scores_gemma":[0.9848195,0.0001521254,0.0004732683,0.0002364821,0.01260162,2.052424e-7,0.000002581649,0.000009291642,0.001704965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5546046,"threshold_uncertainty_score":0.1839542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095647706","doi":"10.1016/s0140-6736(10)61194-4","title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1010,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Eisai; Daiichi-Sankyo; Daiichi Sankyo Europe; Boehringer Ingelheim","keywords":"Warfarin; Dabigatran; Medicine; Atrial fibrillation; Quartile; Stroke (engine); Internal medicine; Randomized controlled trial; Population; Anesthesia; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.07215357664148973,"gpt":0.3455962858138768,"spread":0.2734427091723871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004387157,0.00007945309,0.0005774659,0.00009148701,0.00003627786,0.000007271698,0.0001158287,0.00003976535,0.00006853856],"category_scores_gemma":[0.000126697,0.00004229714,0.0001852614,0.0001534727,0.00008386132,0.00005480107,0.0000290752,0.00005891401,5.75691e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001669259,"about_ca_system_score_gemma":0.00001958434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002788881,"about_ca_topic_score_gemma":0.0007686103,"domain_scores_codex":[0.9990169,0.00009797205,0.000450474,0.0001089688,0.0002484171,0.00007731299],"domain_scores_gemma":[0.9989093,0.0003271296,0.000382312,0.0002793286,0.00008258865,0.00001935487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1577551,0.00001977558,0.8154453,0.00004734792,0.001228285,9.075663e-8,0.0005154308,0.007197885,0.01520108,0.001367722,0.00001283946,0.001209117],"study_design_scores_gemma":[0.08641722,0.0002755787,0.8960407,0.00002481832,0.001100287,2.799322e-7,0.00004355773,0.01426262,0.001528677,0.00004345214,0.0002197215,0.00004304417],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954312,0.00001210768,0.001045171,0.001705466,0.0001915543,0.001358585,0.0001624225,0.000005798254,0.00008762889],"genre_scores_gemma":[0.9987012,0.00000779108,0.0002296533,0.00001333729,0.00080331,0.000002043453,0.00008302302,0.000005019818,0.0001546717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08059544,"threshold_uncertainty_score":0.1724827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108064339","doi":"10.1056/nejmoa1105819","title":"Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":997,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Heart Research Centre","funders":"","keywords":"Acute coronary syndrome; Apixaban; Medicine; Cardiology; Internal medicine; Ticagrelor; Clopidogrel; Intensive care medicine; Aspirin; Myocardial infarction; Rivaroxaban; Atrial fibrillation; Warfarin","retraction":null,"screen_n_in":null,"score":{"opus":0.05491402228194181,"gpt":0.2938655295379597,"spread":0.2389515072560179,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003972613,0.0001545805,0.00051539,0.0002158089,0.00002755982,0.000004977198,0.00008279329,0.00004845359,0.001806292],"category_scores_gemma":[0.00002970002,0.00007944793,0.00008414819,0.0001621886,0.00008546556,0.0001407882,0.00001344289,0.0001989817,0.00001376577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001815546,"about_ca_system_score_gemma":0.00006653397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000189805,"about_ca_topic_score_gemma":0.00000318349,"domain_scores_codex":[0.998849,0.00003955555,0.0004061277,0.0001042627,0.0004364226,0.0001646576],"domain_scores_gemma":[0.9991738,0.00006037751,0.0002500957,0.0001521287,0.000118711,0.0002448619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02013347,0.0000257895,0.8902671,0.00002458028,0.001136384,0.01032887,0.001919744,0.000001480708,0.0007020469,0.0000942425,0.002908895,0.07245745],"study_design_scores_gemma":[0.06556137,0.006740641,0.8695367,0.0003029042,0.0005004177,0.01307637,0.0001106751,0.000004010863,0.0002036394,0.0002348444,0.04361586,0.0001125647],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900317,0.001223156,0.0004627668,0.005526067,0.0004286797,0.000186683,7.462706e-7,0.00001889975,0.002121313],"genre_scores_gemma":[0.9922447,0.001044488,0.001399161,0.0009024833,0.002024391,3.054516e-7,0.000004154175,0.00002089163,0.002359461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07234488,"threshold_uncertainty_score":0.9991062,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112378432","doi":"10.1056/nejmoa1113697","title":"Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":990,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Dabigatran; Warfarin; Medicine; Venous thromboembolism; Placebo; Anesthesia; Cardiology; Atrial fibrillation; Internal medicine; Thrombosis","retraction":null,"screen_n_in":null,"score":{"opus":0.1061845148435807,"gpt":0.3422265839453605,"spread":0.2360420691017798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005712828,0.0001387465,0.0008578326,0.0003510659,0.00001824246,0.00000862353,0.00009261268,0.00006867609,0.001215838],"category_scores_gemma":[0.0009358616,0.00007788148,0.00009222417,0.0002616811,0.00008146524,0.0002262166,0.00002134045,0.0002423126,0.000009409167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003554019,"about_ca_system_score_gemma":0.000134713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000386693,"about_ca_topic_score_gemma":0.00004434488,"domain_scores_codex":[0.9983329,0.00007323352,0.0008327489,0.0001009326,0.0004796794,0.0001805308],"domain_scores_gemma":[0.9986085,0.0004227996,0.0003876913,0.0001680939,0.0001997368,0.0002131811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01170415,0.0002128068,0.2680818,0.0004771062,0.0008045307,0.001074959,0.006379832,0.0002930439,0.03116327,0.001219853,0.04044663,0.638142],"study_design_scores_gemma":[0.1053334,0.003661439,0.798647,0.001044397,0.0005280178,0.0008603095,0.000557577,0.0002050654,0.0008695886,0.001398051,0.08672465,0.0001705437],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806011,0.0006614745,0.0003350957,0.01610376,0.0006923839,0.0004393654,6.284464e-7,0.00001238889,0.001153847],"genre_scores_gemma":[0.991441,0.0007108435,0.001570328,0.0004533203,0.003409781,4.439074e-7,0.000003529824,0.00001696666,0.002393835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6379715,"threshold_uncertainty_score":0.9996972,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011936209","doi":"10.1016/j.amjmed.2009.11.025","title":"Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review","year":2010,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":931,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Inro Consultants (Canada)","funders":"Bayer HealthCare","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Warfarin; Internal medicine; Diabetes mellitus; Heart failure; Cardiology; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1356187412443375,"gpt":0.4369071076600478,"spread":0.3012883664157103,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003605949,0.0003189062,0.00850864,0.0005318369,0.00002505085,0.000005502611,0.0003378028,0.00007571397,0.00008255325],"category_scores_gemma":[0.002603458,0.0001442217,0.001095303,0.001137805,0.0004716937,0.00005120241,0.00005224566,0.0005765552,0.00001088619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007365629,"about_ca_system_score_gemma":0.0003091425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002601468,"about_ca_topic_score_gemma":0.000003102743,"domain_scores_codex":[0.9951712,0.0007153942,0.00294238,0.000140868,0.0008435003,0.0001866862],"domain_scores_gemma":[0.9920351,0.00117828,0.005911844,0.0005373191,0.00021895,0.0001185167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001920427,0.000004504805,0.0003798427,0.633399,0.001096827,0.00008220136,0.00009508707,0.000001999486,0.000001144154,0.0001078921,0.000492433,0.3641471],"study_design_scores_gemma":[0.001472522,0.0009381263,0.0001323758,0.8018464,0.02065352,0.001159033,0.0001134554,0.000005197724,1.23963e-7,0.00004170557,0.1734927,0.0001448323],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001123672,0.9931765,0.0000379596,0.004464683,0.00043795,0.001669373,0.000002420721,0.000006811813,0.00009189544],"genre_scores_gemma":[0.0002564593,0.9969118,0.0001737204,0.000273457,0.002222694,7.293562e-7,0.000008896941,0.00003267988,0.0001196188],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3640023,"threshold_uncertainty_score":0.588119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126206943","doi":"10.1378/chest.11-2304","title":"Antithrombotic Therapy for Atrial Fibrillation","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":919,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Antithrombotic; Aspirin; Clopidogrel; Atrial fibrillation; Stroke (engine); Internal medicine; Cardiology; Thrombosis; Combination therapy; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1253155943558695,"gpt":0.3776564646439776,"spread":0.252340870288108,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003931775,0.00007797177,0.000174807,0.00007812033,0.0001249742,0.00003712621,0.00002923168,0.00004839563,0.0002319667],"category_scores_gemma":[0.0001372988,0.00005787297,0.0002840964,0.00008033161,0.00001669195,0.0002176734,0.000007822257,0.00006701691,0.00004307159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003879817,"about_ca_system_score_gemma":0.0000330342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.161746e-7,"about_ca_topic_score_gemma":7.803545e-8,"domain_scores_codex":[0.9993591,0.00001774034,0.0002057148,0.00006004102,0.0001550419,0.0002023561],"domain_scores_gemma":[0.9995331,0.00008442285,0.000114885,0.0000773394,0.00006645093,0.0001237768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005011045,0.000004073697,0.9553972,0.00004019995,0.0001669341,0.000001115819,0.0002089895,0.00005305558,0.001619401,0.0007992192,0.003022481,0.03818625],"study_design_scores_gemma":[0.003439516,0.0001787955,0.5649217,0.00001794748,0.0001074043,0.00007234586,0.00005304025,0.0001551187,0.0005955662,0.0002771076,0.4300939,0.0000875586],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9770344,0.003134512,0.01010756,0.005038882,0.00259747,0.0006258433,0.000001402656,0.00005287064,0.001407031],"genre_scores_gemma":[0.9687834,0.0005243918,0.005135636,0.0001181553,0.02436313,2.134008e-7,0.000009992364,0.00001696063,0.001048077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4270715,"threshold_uncertainty_score":0.2539872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W146672770","doi":"10.1016/j.jacc.2012.11.064","title":"Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":892,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Biosense Webster; St. Jude Medical","keywords":"Medicine; Cryoablation; Pulmonary vein; Atrial fibrillation; Ablation; Surgery; Balloon; Drug; Cardiology; Internal medicine; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.02962908843750736,"gpt":0.3010682417419976,"spread":0.2714391533044902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003702477,0.00008793244,0.000755553,0.0001484014,0.00003653528,0.000002276315,0.0001077034,0.00004650289,0.00001758709],"category_scores_gemma":[0.0004179727,0.00005774774,0.0008197279,0.0002513887,0.0001729129,0.00008825282,0.00003936494,0.00006667177,0.000001341519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004884754,"about_ca_system_score_gemma":0.00009904767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001264493,"about_ca_topic_score_gemma":4.786715e-7,"domain_scores_codex":[0.998794,0.0001328673,0.0006463332,0.00007791959,0.0002316047,0.000117305],"domain_scores_gemma":[0.9976671,0.0003575316,0.001345973,0.0001693501,0.0004185505,0.00004143573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00387056,0.000005360579,0.9429632,0.00009566161,0.001019793,0.000007372582,0.00003094262,0.01484041,0.01828009,0.0009393253,0.006136891,0.01181042],"study_design_scores_gemma":[0.002101194,0.0017312,0.9603223,0.00004973239,0.0006879399,0.0002138683,0.0002796454,0.002067475,0.0008508324,0.001309288,0.03029119,0.00009528883],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906398,0.0001854859,0.001941685,0.005119933,0.0007596118,0.000622067,0.00002156936,0.000004672178,0.0007051633],"genre_scores_gemma":[0.9945284,0.00008421509,0.001579744,0.00004255505,0.003449806,5.571314e-7,0.000002918465,0.000009921565,0.0003019393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0241543,"threshold_uncertainty_score":0.2354884,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133730204","doi":"10.1161/circulationaha.108.772582","title":"Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation","year":2008,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":891,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital; Montreal Heart Institute","funders":"","keywords":"Medicine; Atrial fibrillation; Ablation; Catheter ablation; Pulmonary vein; Internal medicine; Cardiology; Randomized controlled trial; Quality of life (healthcare); Clinical endpoint; Quinidine; Multicenter trial; Crossover study; Anesthesia; Multicenter study","retraction":null,"screen_n_in":null,"score":{"opus":0.07755947946427998,"gpt":0.3279532701755316,"spread":0.2503937907112516,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001475659,0.0001116293,0.000187163,0.0001479903,0.0001884437,0.00001506733,0.00002199348,0.00009654021,0.00006898703],"category_scores_gemma":[0.000160608,0.000111617,0.0002966913,0.000179556,0.00002638401,0.0002278109,0.00001008029,0.00003658169,0.00007193907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009714279,"about_ca_system_score_gemma":0.00004506731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000771933,"about_ca_topic_score_gemma":8.669592e-7,"domain_scores_codex":[0.9990951,0.00002232074,0.0002840655,0.0002155168,0.0002335029,0.0001494723],"domain_scores_gemma":[0.9993933,0.0001205455,0.0001359049,0.0001764626,0.0001240248,0.00004971557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003774049,0.000007117173,0.9242936,0.0001463709,0.0003145474,0.000005337192,0.001393491,0.02177815,0.004283434,0.004706283,0.0009885844,0.03830903],"study_design_scores_gemma":[0.008952342,0.000155673,0.9085775,0.00002259534,0.000276809,0.00001709564,0.00004164246,0.05174508,0.0004098312,0.0004784682,0.02908537,0.0002375897],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777295,0.0001250441,0.01758708,0.0009429645,0.0009735548,0.00113699,0.000004081965,0.0001388761,0.001361884],"genre_scores_gemma":[0.9934692,0.00003362346,0.001342783,0.0000315279,0.004373327,0.000002196969,0.0003462587,0.00002263168,0.0003784002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03807144,"threshold_uncertainty_score":0.4551607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103053426","doi":"10.1161/circulationaha.107.750000","title":"Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range","year":2008,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":873,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Atrial fibrillation; Aspirin; Relative risk; Confidence interval; Quartile; Internal medicine; Warfarin; Cardiology; Population; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.05568480677877638,"gpt":0.3213220748878812,"spread":0.2656372681091048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006645063,0.000122579,0.0003874415,0.0001466844,0.00004064939,0.00001228777,0.00005036719,0.00008284056,0.00009106854],"category_scores_gemma":[0.000110111,0.00009383904,0.0001029486,0.000165037,0.00007090797,0.0001579189,0.000009007519,0.00006149503,0.000002313207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007062996,"about_ca_system_score_gemma":0.00002491952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003477576,"about_ca_topic_score_gemma":0.00002545288,"domain_scores_codex":[0.9985405,0.0001764417,0.0005620883,0.0001611957,0.0004519334,0.0001078332],"domain_scores_gemma":[0.9991872,0.000273021,0.0003028655,0.0001282242,0.00008735642,0.00002138776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003927818,0.0000126056,0.9274233,0.00001227316,0.0001121026,7.552986e-7,0.0002818989,0.0006899288,0.0658004,0.0008055479,0.00002381539,0.0009095502],"study_design_scores_gemma":[0.01228258,0.0000829676,0.977566,0.00003144106,0.00002610797,0.000002013353,0.00002403698,0.007519827,0.001950688,0.0001160367,0.000312028,0.0000862536],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969883,0.0004064175,0.0003835914,0.001237915,0.0000837202,0.0007721488,0.00003206218,0.00001224942,0.00008362604],"genre_scores_gemma":[0.9993174,0.0002881643,0.000008796395,0.0001260322,0.00006408208,0.000001320756,0.0001482213,0.00001049729,0.00003545171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06384971,"threshold_uncertainty_score":0.3826645,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2886678431","doi":"10.1161/circulationaha.115.018614","title":"Atrial Fibrillation Begets Heart Failure and Vice Versa","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":867,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; School of Medicine, Boston University; Doris Duke Charitable Foundation","keywords":"Medicine; Ejection fraction; Hazard ratio; Cardiology; Internal medicine; Heart failure; Atrial fibrillation; Framingham Heart Study; Confidence interval; Proportional hazards model; Framingham Risk Score; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.03452820795657843,"gpt":0.2980895906947484,"spread":0.26356138273817,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001185034,0.00007786043,0.0001373077,0.000087742,0.00006635657,0.00001756078,0.00001309187,0.00006990007,0.0001292041],"category_scores_gemma":[0.0001361193,0.00005692513,0.00009115059,0.0001036061,0.00002331568,0.0002088582,0.0000167821,0.00002244979,0.00009998662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004865627,"about_ca_system_score_gemma":0.00001692501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005599691,"about_ca_topic_score_gemma":0.000003057395,"domain_scores_codex":[0.9993751,0.00002402516,0.0001627517,0.0001692512,0.0001673522,0.0001015213],"domain_scores_gemma":[0.9996104,0.00009796223,0.0000584483,0.0001225779,0.00005311177,0.00005756292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008568724,4.08303e-7,0.9739345,0.00001957857,0.00003070782,7.508966e-7,0.00004238705,0.00005297214,0.01076922,0.00129553,0.0005144225,0.01325384],"study_design_scores_gemma":[0.001765196,0.00002531974,0.9092543,0.00003843238,0.00007913633,0.000008453166,0.00001557913,0.0004195252,0.0002325784,0.0004848388,0.0875923,0.00008431444],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800996,0.0001521934,0.002197829,0.01623913,0.0002373108,0.0003734895,0.000001899479,0.00009756993,0.000601035],"genre_scores_gemma":[0.997359,0.00002068886,0.0005373727,0.00007715427,0.001715304,2.743451e-7,0.00001953936,0.00001053822,0.0002600675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08707788,"threshold_uncertainty_score":0.2321339,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140485936","doi":"10.1161/circep.109.849638","title":"The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk","year":2009,"lang":"en","type":"article","venue":"Circulation Arrhythmia and Electrophysiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":866,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Atrial fibrillation; Hazard ratio; Stroke (engine); Internal medicine; Cardiology; Proportional hazards model; Antithrombotic; Observational study; Atrial tachycardia; Risk factor; Heart failure; Diabetes mellitus; Prospective cohort study; Confidence interval; Catheter ablation","retraction":null,"screen_n_in":null,"score":{"opus":0.03412694900801468,"gpt":0.3012040881799116,"spread":0.267077139171897,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001909286,0.0001878357,0.0003682684,0.00008694164,0.0006108091,0.000066156,0.00004527678,0.0001681249,0.00001166283],"category_scores_gemma":[0.0008026493,0.0001432654,0.0001034374,0.000164864,0.00008868013,0.0001228395,0.00002992621,0.0002664604,0.00002572018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004424275,"about_ca_system_score_gemma":0.0000432659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008100428,"about_ca_topic_score_gemma":0.000008747852,"domain_scores_codex":[0.9986557,0.0001602184,0.0003737777,0.0003384402,0.0001574857,0.0003144123],"domain_scores_gemma":[0.9971958,0.002165646,0.0002131874,0.0002444602,0.00006147964,0.000119419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005852186,0.000001457,0.9363633,0.00001214044,0.0001696543,0.00001132861,0.0001619019,0.000255846,0.00451359,0.007947485,0.0002749256,0.0497031],"study_design_scores_gemma":[0.001500957,0.0002344316,0.9719271,0.00001195395,0.0003469696,0.00002526498,0.00003871565,0.001203548,0.00004118812,0.01567825,0.008838225,0.0001533817],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922275,0.002054099,0.0008231468,0.003978926,0.0001535914,0.0004197441,0.00002498638,0.00006979193,0.000248218],"genre_scores_gemma":[0.992623,0.001385712,0.0002907541,0.0001403178,0.005103145,0.000002133802,0.0002073788,0.00001436855,0.0002331568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04954971,"threshold_uncertainty_score":0.5842193,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105454146","doi":"10.1161/circulationaha.111.019893","title":"Atrial Fibrillation Pathophysiology","year":2011,"lang":"en","type":"review","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Université de Montréal; AstraZeneca","keywords":"Medicine; Atrial fibrillation; Reentry; Cardiology; Cardiac arrhythmia; Population; Pathophysiology; Internal medicine; Neuroscience; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1558145796136173,"gpt":0.3803583910210889,"spread":0.2245438114074716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001474046,0.0002667488,0.001198723,0.0002882726,0.00006348153,0.00001580216,0.00005308157,0.000395098,0.0003634724],"category_scores_gemma":[0.0001295292,0.0002215476,0.001243689,0.0003002076,0.00002656195,0.0000869364,0.00003884344,0.0001313725,0.000720134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000113112,"about_ca_system_score_gemma":0.0001170708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004992793,"about_ca_topic_score_gemma":2.844688e-7,"domain_scores_codex":[0.9986392,0.0001105617,0.0005914951,0.0003457512,0.0001440018,0.0001689974],"domain_scores_gemma":[0.9989917,0.0001052458,0.0004256369,0.0003478004,0.00006328213,0.00006639225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002063609,6.337478e-7,0.001417369,0.003351669,0.0001680465,0.000002706468,0.00001597305,0.00001058209,7.28894e-7,0.00163152,0.00009548762,0.9932846],"study_design_scores_gemma":[0.0003323496,0.00002621859,0.003914188,0.001213923,0.002073688,0.00001188842,0.000001539684,0.00006337139,6.423447e-8,0.0006029046,0.9915568,0.0002030949],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003632396,0.9952192,0.0002801209,0.00002528874,0.0008181147,0.001262384,0.000005376076,0.0001299539,0.00222326],"genre_scores_gemma":[0.0002360769,0.9919081,0.0001954578,0.00001607188,0.006196589,0.000002007366,0.0009740668,0.00004966603,0.000421946],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9930816,"threshold_uncertainty_score":0.9256106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1547546593","doi":"10.1016/j.jacc.2013.07.104","title":"The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":826,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Schering-Plough; GlaxoSmithKline; Pfizer","keywords":"Medicine; Dabigatran; Atrial fibrillation; Stroke (engine); Cardiology; Ischemic stroke; Internal medicine; Anesthesia; Warfarin; Ischemia","retraction":null,"screen_n_in":null,"score":{"opus":0.01131656921879807,"gpt":0.25337952601733,"spread":0.242062956798532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139011,0.00008060053,0.0005171621,0.00006470062,0.00005315048,0.000003978871,0.00007116033,0.0000287339,0.0000030846],"category_scores_gemma":[0.0006453647,0.00003762236,0.0001751701,0.0001310174,0.0003398914,0.00004109876,0.00003579032,0.0001037971,1.606759e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002538873,"about_ca_system_score_gemma":0.00003209632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001379203,"about_ca_topic_score_gemma":0.000001339175,"domain_scores_codex":[0.9988719,0.0002431972,0.0005429301,0.0000607857,0.0001915885,0.00008957541],"domain_scores_gemma":[0.9975048,0.001199967,0.00101435,0.000116391,0.0001370396,0.00002739991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006868014,0.000001043173,0.984837,0.00002155237,0.0002219002,9.022897e-7,0.00006615531,0.00009448834,0.009895308,0.0001244593,0.0003624809,0.003687885],"study_design_scores_gemma":[0.002112683,0.002284214,0.989985,0.00008665713,0.0002716822,0.00002260068,0.0004078303,0.0001987995,0.003705244,0.00003068916,0.0008474684,0.00004710588],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968308,0.0001000702,0.000005636586,0.002067162,0.0002187429,0.0004979695,0.00003106507,9.930167e-7,0.0002476289],"genre_scores_gemma":[0.999517,0.0001585385,0.00005215393,0.00001676864,0.0002309784,6.491733e-7,9.459422e-7,0.000004955552,0.000018039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006190064,"threshold_uncertainty_score":0.1534195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111995867","doi":"10.1016/j.jacc.2004.11.070","title":"Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers","year":2005,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":825,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Atrial fibrillation; Cardiology; Internal medicine; Myocardial infarction; Cardioversion; Angiotensin-converting enzyme; Relative risk; Randomized controlled trial; Angiotensin receptor; Angiotensin Receptor Blockers; Angiotensin II; Confidence interval; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.03696245379429191,"gpt":0.3252225926067658,"spread":0.2882601388124739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006466815,0.0002550961,0.003271149,0.0003972986,0.00004466255,0.00000369586,0.0001117037,0.0001448397,0.00000532766],"category_scores_gemma":[0.0003247006,0.0001503053,0.001868939,0.000599933,0.000384815,0.00006346907,0.00008202397,0.0002310099,7.099013e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001161829,"about_ca_system_score_gemma":0.0004082287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005240966,"about_ca_topic_score_gemma":0.000001256243,"domain_scores_codex":[0.9975404,0.0004604467,0.001295813,0.0001752651,0.0003605451,0.0001675018],"domain_scores_gemma":[0.9945583,0.0003543074,0.004421677,0.00025179,0.0003444632,0.00006940908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002494002,0.000004085417,0.01709879,0.001594279,0.006435269,0.00004568327,0.00004732778,0.0005376362,0.0001304015,0.00005285494,0.01205741,0.9595023],"study_design_scores_gemma":[0.001319097,0.001235039,0.001406102,0.003612594,0.005667788,0.00110509,0.00008847338,0.00001474266,0.00003351018,0.000009680463,0.9853483,0.000159611],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0238112,0.971265,0.00007999189,0.002919423,0.0007721225,0.001053886,0.00003644714,0.00000914798,0.00005284769],"genre_scores_gemma":[0.01236953,0.9753003,0.00465927,0.00002371236,0.007254887,2.836154e-7,0.000008231132,0.00004389568,0.0003399462],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9732909,"threshold_uncertainty_score":0.6129271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2514338974","doi":"10.1056/nejmoa1607887","title":"Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":787,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital; McMaster University; Population Health Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Bolus (digestion); Rivaroxaban; Anesthesia; Apixaban; Liter; Prospective cohort study; Internal medicine; Gastroenterology; Surgery; Warfarin; Atrial fibrillation","retraction":null,"screen_n_in":null,"score":{"opus":0.04867069631681006,"gpt":0.3274264553971103,"spread":0.2787557590803003,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005759654,0.0001540972,0.0005676923,0.0002287566,0.00005065699,0.000009122046,0.00006963592,0.00006733689,0.0003108204],"category_scores_gemma":[0.0008198991,0.00006783312,0.0001017971,0.0001558788,0.00005886899,0.0001506101,0.0000126154,0.0001102595,0.000002616661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007433219,"about_ca_system_score_gemma":0.00009163425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007270909,"about_ca_topic_score_gemma":0.00001076384,"domain_scores_codex":[0.9986635,0.00003012988,0.0004949261,0.0001146646,0.0004861015,0.0002106527],"domain_scores_gemma":[0.9983584,0.0005609236,0.0004663767,0.0000921116,0.0002546046,0.0002676249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01005961,0.00003192197,0.5902689,0.0000770951,0.003852092,0.0003238234,0.001091497,0.000005830604,0.05835767,0.000401149,0.07439445,0.2611359],"study_design_scores_gemma":[0.4152539,0.01355164,0.1868529,0.004150075,0.005199404,0.0007167823,0.0003485224,0.00005573909,0.006296236,0.00111575,0.3659859,0.0004731947],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9181681,0.0004139313,0.007085112,0.0716389,0.001262324,0.0004875024,0.00001193755,0.00003933868,0.0008928595],"genre_scores_gemma":[0.9818375,0.0001841219,0.0005599397,0.0003675388,0.01048385,4.646588e-7,0.00000989927,0.00002423533,0.006532487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4051943,"threshold_uncertainty_score":0.3403265,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3023891555","doi":"10.1016/j.hrthm.2016.05.028","title":"EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication","year":2016,"lang":"en","type":"review","venue":"Heart Rhythm","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":766,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; McGill University; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Cardiology; Law; Internal medicine; Political science","retraction":{"nature":"Reinstatement","openalex_flagged":false},"screen_n_in":null,"score":{"opus":0.1682134140001504,"gpt":0.4262970483157168,"spread":0.2580836343155664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000773809,0.0004601916,0.002102209,0.0002249066,0.0001677908,0.00006609086,0.00005834551,0.0005121062,0.0005433086],"category_scores_gemma":[0.0006172606,0.0003316312,0.001073963,0.0002603112,0.0001468547,0.00007339502,0.00006598977,0.0002794717,0.001295009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001023698,"about_ca_system_score_gemma":0.0002158123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004819771,"about_ca_topic_score_gemma":5.183007e-7,"domain_scores_codex":[0.9968299,0.0003990742,0.00137851,0.0007197402,0.0003584997,0.0003142697],"domain_scores_gemma":[0.9975952,0.0008653707,0.0004530829,0.0006726159,0.0001828938,0.0002308699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001465255,0.00001097903,0.000368231,0.001918201,0.0003607357,0.00002358247,0.00003461588,2.207804e-8,0.000001660341,0.0007775862,0.007168596,0.9891893],"study_design_scores_gemma":[0.00121834,0.0001913111,0.001369737,0.004397917,0.0007125455,0.0005676519,0.000007639638,0.000001837317,5.79521e-7,0.00004251081,0.9911542,0.0003357338],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006089928,0.9887455,0.0002080259,0.004701733,0.00169185,0.00289916,0.0001509592,0.0002631961,0.0007306099],"genre_scores_gemma":[0.00005203635,0.9854503,0.0003689048,0.0005410681,0.009548661,0.00002959667,0.0007121649,0.00008393591,0.003213357],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9888535,"threshold_uncertainty_score":0.9999136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2767660506","doi":"10.1016/s0140-6736(17)32458-3","title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":756,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Rivaroxaban; Medicine; Aspirin; Placebo; Coronary artery disease; Cardiology; Internal medicine; Double blind; Anesthesia; Atrial fibrillation; Warfarin; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08657811531858285,"gpt":0.3517472701356689,"spread":0.265169154817086,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004846078,0.000184004,0.0007262114,0.00008108744,0.0001863075,0.000155431,0.0003734947,0.00003591383,0.0001818249],"category_scores_gemma":[0.0001155075,0.00008642828,0.00006632591,0.00005431163,0.00009612233,0.0004375359,0.00006597224,0.000133565,0.00001618491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004464364,"about_ca_system_score_gemma":0.00008733408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004070922,"about_ca_topic_score_gemma":0.0001732698,"domain_scores_codex":[0.9986997,0.00007958886,0.0002834025,0.0002494598,0.0004463347,0.0002414648],"domain_scores_gemma":[0.9985412,0.000100549,0.0002911806,0.0008678458,0.00009312398,0.0001061401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.538592,0.00004455672,0.4606587,0.00001051853,0.0001751222,0.00001552323,0.00004814663,0.00003905256,7.501708e-7,0.00006346879,0.0001409322,0.0002111767],"study_design_scores_gemma":[0.6517645,0.0004762379,0.3453659,0.00006584125,0.0001831484,0.00000100426,0.00002318672,0.0002835652,0.000001775353,0.00001778116,0.001716784,0.0001002674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864842,0.00001144457,0.00004369413,0.003238174,0.000306828,0.005875965,0.00001113655,0.00005188386,0.003976717],"genre_scores_gemma":[0.9925258,0.00001579722,0.0001833869,0.0003186967,0.001667704,0.0001188645,0.0001096598,0.00002607751,0.005034085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1152929,"threshold_uncertainty_score":0.3524443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136065216","doi":"10.1161/01.cir.0000145172.55640.93","title":"Selecting Patients With Atrial Fibrillation for Anticoagulation","year":2004,"lang":"en","type":"review","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":756,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; Hjerteforeningen; American Heart Association","keywords":"Medicine; Atrial fibrillation; Aspirin; Stroke (engine); Warfarin; Antithrombotic; Internal medicine; Cardiology; Diabetes mellitus","retraction":null,"screen_n_in":null,"score":{"opus":0.09138298063893038,"gpt":0.3676567330272203,"spread":0.2762737523882899,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001789067,0.0003084365,0.001006106,0.0003286273,0.0001600797,0.00005730768,0.00003863529,0.0002738952,0.00002220388],"category_scores_gemma":[0.000219308,0.0002470296,0.0006566257,0.0004728062,0.00001690838,0.0001970373,0.00001438887,0.00009767523,0.00002551499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003984302,"about_ca_system_score_gemma":0.0002374856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003774314,"about_ca_topic_score_gemma":8.669381e-7,"domain_scores_codex":[0.9983814,0.0000426971,0.0006209117,0.0003957257,0.0003499508,0.0002092782],"domain_scores_gemma":[0.9986274,0.0001892474,0.000638058,0.0002265914,0.0002580427,0.00006069824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001178018,0.000003184677,0.1000086,0.01364564,0.0003443659,4.084195e-7,0.00002660869,0.001774314,1.991672e-7,0.0005375613,0.00001144554,0.8835298],"study_design_scores_gemma":[0.005415191,0.0002022538,0.1057738,0.01158984,0.007201177,0.000007415771,0.000004355502,0.0009896761,4.519077e-7,0.0002544517,0.8679179,0.0006435236],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001492686,0.9730446,0.01522094,0.00006228608,0.0006730198,0.009035537,0.00002450583,0.0002498754,0.0001965147],"genre_scores_gemma":[0.03276284,0.9372923,0.005370163,0.00001913302,0.009653389,0.00001782777,0.01432602,0.0002920529,0.0002662646],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8828864,"threshold_uncertainty_score":0.9999982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}